Give it a break Jay. !!!! . All of those who invested in AHZ back in the early days did so thinking the HSV2 vaccine was going to be a roaring success . It wasn’t the case and those that invested back then need to be greatful WP came onto the scene. WP realised the gem in the companies assets and divested everything else . Quite frankly WP has done a outstanding job to keep this company out of liquidation therefore your argument regarding dilution is irrelevant . Long term share holders need to be greatful they have the opportunity to regain their original investment and bag a profit . Most CEOs would have let this company slide into liquidation . This in essence IS a new company with a outstanding product and for those original investors who still hold a great second chance ( not something seen very often ) GLTATH
AVR Price at posting:
$28.30 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)